MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
HRYZ Biotech Co.
Mayo Clinic
Mayo Clinic
GlaxoSmithKline
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute